Ciudad de la Habana, Cuba

Lisette Gonzalez Chavez



Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Lisette Gonzalez Chavez: Pioneering Thrombolytic Treatments

Introduction

Lisette Gonzalez Chavez, a dedicated inventor based in Ciudad de la Habana, Cuba, is making significant strides in the field of pharmaceutical formulations. With a focus on enhancing the treatment of acute hemorrhoid diseases and related thrombotic conditions, she has developed innovative formulations for rectal administration that leverage thrombolytically-active agents.

Latest Patents

Lisette holds one patent titled "Formulations for the rectal administration of thrombolytically-active agents." This groundbreaking invention consists of pharmaceutical formulations in suppository form that contain thrombolytic agents. These formulations are designed to penetrate the rectal mucous effectively, providing an advanced solution for treating acute hemorrhoid diseases and other thrombotic-origin diseases.

Career Highlights

Currently, Lisette is associated with the Centro de Ingeniería Genética y Biotecnología, where her research and development efforts contribute to the advancement of medical treatments. Her work is essential not only within her organization but also within the broader medical community, as it addresses critical health issues affecting many individuals.

Collaborations

Throughout her career, Lisette has collaborated with notable coworkers, including Maria Acelia Marrero Miragaya and Ana Aguilera Barreto. These partnerships have fostered a collaborative environment that enhances the development and innovation of new therapeutic solutions, further establishing Lisette as a significant figure in her field.

Conclusion

Lisette Gonzalez Chavez exemplifies the spirit of innovation in pharmaceutical science. Her contributions, particularly through her patent for thrombolytic formulations, reflect her commitment to improving healthcare outcomes. As she continues her work at the Centro de Ingeniería Genética y Biotecnología and collaborates with skilled professionals, she remains poised to impact the medical landscape positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…